Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review

N Pittman, SM Rawn, M Wang, A Masetto… - …, 2018 - academic.oup.com
Objectives Almost all patients with SSc have gastrointestinal manifestations. Small intestinal
bacterial overgrowth (SIBO) occurs in 30–60% of patients and leads to malnutrition and …

High prevalence of occult left heart disease in scleroderma-pulmonary hypertension

…, K Boutet, A Serban, A Masetto… - European …, 2013 - Eur Respiratory Soc
Our study aimed to determine the prevalence of occult left-heart disease in patients with
scleroderma and pulmonary hypertension. In patients with pulmonary hypertension (mean …

Calcinosis is associated with digital ischaemia in systemic sclerosis—a longitudinal study

…, N Khalidi, P Docherty, E Kaminska, A Masetto… - …, 2016 - academic.oup.com
Objective. To determine if ischaemia is a causal factor in the development of calcinosis in
SSc. Methods. Patients with SSc were assessed yearly. Physicians reported the presence of …

Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III

…, J Pope, A Fontaine, A Masetto… - Arthritis care & …, 2015 - Wiley Online Library
Objective Systemic sclerosis (SSc; scleroderma) is associated with decreased saliva production
and interincisal distance, more missing teeth, and periodontal disease. We undertook …

[HTML][HTML] Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 …

…, I Marie, M Martin, T Martin, A Masetto… - Journal of …, 2020 - Elsevier
Objective Contagious disease outbreaks and related restrictions can lead to negative
psychological outcomes, particularly in vulnerable populations at risk due to pre-existing medical …

2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the …

…, P Docherty, E Kaminska, A Masetto… - Arthritis care & …, 2015 - Wiley Online Library
Objective The goal of this study was to determine the sensitivity of the new 2013 classification
criteria for systemic sclerosis (SSc; scleroderma) in an independent cohort of SSc subjects …

Anti-carbamylated protein antibody levels correlate with anti-Sa (citrullinated vimentin) antibody levels in rheumatoid arthritis

…, G Boire, AJ de Brum-Fernandes, A Masetto… - The Journal of …, 2016 - jrheum.org
Objective. The presence of anticitrullinated protein antibodies (ACPA) in rheumatoid arthritis
(RA) indicates a breach in immune tolerance. Recent studies indicate that this breach …

[HTML][HTML] Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in …

…, AJ de Brum-Fernandes, P Liang, A Masetto… - Arthritis research & …, 2016 - Springer
Background Age, C-Reactive Protein (CRP) and autoantibodies (Abs) are associated with
worse prognosis in patients with recent-onset inflammatory polyarthritis (EPA). Serum 14-3-3η …

Validation of the self‐efficacy for managing chronic disease scale: a Scleroderma Patient‐Centered Intervention Network cohort Study

…, B Korman, M Larche, P Liang, A Masetto… - Arthritis care & …, 2016 - Wiley Online Library
Objective Self‐management programs for patients with chronic illnesses, including rheumatic
diseases, seek to enhance self‐efficacy for performing health management behaviors. No …

Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study

…, I Marie, M Martin, T Martin, A Masetto… - The Lancet …, 2021 - thelancet.com
Background Pain is an important and detrimental feature of systemic sclerosis but is often
overlooked or deprioritised in research and clinical care. Raynaud's phenomenon, arthritis, …